TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/03/2026
Back to search
Official data from USPTO
IONIS PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
02/05/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
12/10/2015
Registration date
02/04/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2020
Last transaction
02/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/03/2019
First use in commerce
12/03/2019
Drawing code
3
Owner type
03
Owner location
Carlsbad, CA
Examiner
PARKS, KIMBERLY L
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "IONIS PHARMACEUTICALS" to the right of a pyramid design element.
Holders and representatives
Holders
IONIS PHARMACEUTICALS, INC.
IONIS PHARMACEUTICALS, INC.
Isis Pharmaceuticals, Inc.
Representatives
Brian Focarino Cooley LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
diagnostic preparations and human therapeutics for medical useantisense oligonucleotides
Publications
History of USPTO decisions and trademark events.
57 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/03/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/04/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/25/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/25/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/25/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/25/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/31/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/30/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/27/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/26/2019
EX5G
SOU EXTENSION 5 GRANTED
12/26/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/26/2019
IUAF
USE AMENDMENT FILED
12/17/2019
EXT5
SOU EXTENSION 5 FILED
12/17/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/17/2019
EISU
TEAS STATEMENT OF USE RECEIVED
12/17/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/15/2019
EX4G
SOU EXTENSION 4 GRANTED
06/13/2019
EXT4
SOU EXTENSION 4 FILED
06/13/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/13/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/21/2018
EX3G
SOU EXTENSION 3 GRANTED
12/19/2018
EXT3
SOU EXTENSION 3 FILED
12/19/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/19/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/15/2018
EX2G
SOU EXTENSION 2 GRANTED
06/13/2018
EXT2
SOU EXTENSION 2 FILED
06/13/2018
EEXT
SOU TEAS EXTENSION RECEIVED
06/13/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/16/2017
EX1G
SOU EXTENSION 1 GRANTED
12/14/2017
EXT1
SOU EXTENSION 1 FILED
12/14/2017
EEXT
SOU TEAS EXTENSION RECEIVED
12/14/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/20/2017
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/04/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/23/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2016
PUBO
PUBLISHED FOR OPPOSITION
10/25/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/15/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/15/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2016
GNRT
NON-FINAL ACTION E-MAILED
03/24/2016
CNRT
NON-FINAL ACTION WRITTEN
03/24/2016
DOCK
ASSIGNED TO EXAMINER
03/22/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/03/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/16/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2015
NWAP
NEW APPLICATION ENTERED
12/14/2015
Continuous trademark protection
Get notified about every new filing that threatens IONIS PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.